South Carolina Patent of the Month – June 2023

Poly-Med, Inc., a leading medical device company specializing in innovative materials and technologies, has recently patented new technology in the field of stereolithography (SLA) with their new photopolymerizable compounds and compositions. These compounds have the potential to revolutionize the manufacturing process of articles such as medical devices and coatings.

The key feature of Poly-Med’s invention is a photopolymerizable compound that comprises a polyaxial central core (CC) and 2-4 arms extending from the central core. The arms are of the formula (A)-(B) or (B)-(A), where at least one of the arms contains a light-reactive functional group (Q). The central core and arms are formed through the ring-opening polymerization of specific monomers, such as trimethylene carbonate (T), glycolide, lactide, or p-dioxanone.

These innovative compounds can be used to create light-curable compositions, which, when combined with a photoinitiator, can be used in various photopolymerization processes, including 3D printing and coating applications. In 3D printing, the photopolymerizable composition is exposed to light, causing it to solidify and form a printed article with high accuracy and precision. Similarly, in coating applications, the composition is applied to a surface and then cured with actinic radiation, resulting in a solid coating.

One of the advantages of Poly-Med’s photopolymerizable compounds and compositions is their biodegradability. This means that articles produced using these materials have a limited lifetime and can naturally degrade over time, making them suitable for applications such as temporary coatings on medical devices or biodegradable meshes for tissue repair.

Poly-Med’s compounds and compositions also address concerns regarding the safety and efficacy of photopolymerized materials. They have been designed with a focus on biocompatibility and cytotoxicity, ensuring that the resulting articles are safe for use in contact with living entities.

The versatility of these compounds is evident in the various compositions that can be formulated. Different combinations of the central core, arms, and functional groups allow for a wide range of properties and applications. The molecular mass and viscosity of the compositions can be adjusted to meet specific requirements, making them adaptable to different manufacturing processes.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts